NHS pathways & implementation
Apos® is a NICE-recommended (HTG671) medical device for knee osteoarthritis, selected for NHS England’s MedTech Funding Mandate policy.
NICE HTG671
A clinically led, non-invasive option for knee osteoarthritis.
For patients
Apos® is available via the NHS, in a growing number of services that have adopted the treatment pathway. If you think it could be right for you, ask your healthcare professional about local access and suitability.
Available in NHS services
Apos® can sit alongside existing conservative care, helping patients explore a personalised, non-invasive option before surgery.
Start with a conversation
Ask your GP, physiotherapist, orthotist or MSK team whether Apos® is available through your local pathway, or get in touch and we can advise if there is NHS coverage in your area.
Patient stories & evidence
Explore patient experiences and the NHS case studies behind local adoption, pathway design and patient choice.
Official resourceNHS Supply Chain articleNHS Supply Chain
Read the official NHS Supply Chain article on clinically proven footwear designed to reduce knee pain and improve joint function.
Read the official article
Official videoWatch Bev’s storyWigan
Beverley shares how Apos® supported her osteoarthritis care in Wigan.
Open video on YouTubeNHS evidence
Official NHS and partner resources showing how Apos® is being considered and delivered in practice.
NHS Supply Chain
NHS Supply Chain
Health Innovation Manchester
Health Innovation Yorkshire & Humber
NICE · HTG671
Read the official recommendations and information for AposHealth® for knee osteoarthritis.
NICE · HTG671
Review the NICE resource impact summary report and modelling tools behind the five-year case.
NHS England
See NHS England’s official policy guidance: eligible technologies must be clinically effective and cost-saving within three years.
AposHealth® UK
Explore the clinical evidence and publications behind Apos®.
For commissioners & clinicians
Apos® integrates into orthotics-led and physiotherapy / MSK-led pathways, supporting elective recovery and helping teams deliver cost savings. More than 70 clinical studies and publications contribute to the evidence base.
Strategic alignment
Apos® aligns with the NHS 10 Year Health Plan: supporting prevention and earlier intervention, care closer to home and productive use of NHS resources. It is a non-surgical option for adults with knee osteoarthritis who meet the criteria for total knee replacement but prefer to avoid surgery.
Orthotics-led
Apos® can sit alongside knee brace provision and enables direct cost comparison modelling.
Physiotherapy / MSK-led
Add Apos® to community MSK interventions and give patients another meaningful choice.
Evidence-led adoption
A non-invasive option can help teams manage demand while supporting informed patient choice.
Implementation support
AposHealth supports NHS adopters from pathway design through training and outcome monitoring.
Integrate Apos® into orthotics-led or physiotherapy / MSK-led pathways with practical support from our team.
Access economic modelling, a full implementation toolkit and one-day clinical training for your staff.
Track patient progress with PROMs and digitised gait analysis, supporting local evaluation and case study development.
Talk to AposHealth® UK
Discuss pathway design, training, economic modelling and access to the full implementation toolkit.
